In the last 10 years the understanding of hyperlipidaemia has advanced greatly. This pocketbook provides a practical approach to therapy, addresses common clinical problems and looks to the future of treatment for the condition, focusing on new therapeutic targets. In essence it translates clinical trial science into everyday clinical practice.
In the last 10 years the understanding of hyperlipidaemia has advanced greatly. This pocketbook provides a practical approach to therapy, addresses common clinical problems and looks to the future of treatment for the condition, focusing on new therapeutic targets. In essence it translates clinical trial science into everyday clinical practice.
John Betteridge is Professor of of Endrocrinology and Metabolism at University College, London UK.
Inhaltsangabe
* 1: Professor Guy De Backer: Epidemiology of cardiovascular disease: the scale of the problem * 2: Joanna Gouni-Berthold and Wilhelm Krone: Lipids, lipoproteins and atherogenesis * 3: Catherine McGorrian, Tora Leong, Ralph D'Agostino, Marie-Therese Coney and Ian M. Graham: Risk estimation systems in clinical use: SCORE, HeartScore, Framingham, PROCAM, ASSIGN and QRISK * 4: Anton F. H. Stalenhoef: Primary dyslipidaemias * 5: Rafael Carmena and José T Real: Secondary dyslipidemias * 6: Jonathan Morrell and Jacqueline Morrell: Diet and lifestyle * 7: D. John Betteridge: Pharmacological therapy: Statins * 8: D. John Betteridge: Pharmacological therapy: Non-Statin Drugs * 9: Anthony S. Wierzbicki: Combination therapy for the management of hyperlipidaemia * 10: D. John Betteridge: Recent lipid-lowering trials in perspective: Implications for therapy * 11: Manish Kalla and Julian Halcox: Vascular imaging * 12: John Reckless: Common problems in lipid management
* 1: Professor Guy De Backer: Epidemiology of cardiovascular disease: the scale of the problem * 2: Joanna Gouni-Berthold and Wilhelm Krone: Lipids, lipoproteins and atherogenesis * 3: Catherine McGorrian, Tora Leong, Ralph D'Agostino, Marie-Therese Coney and Ian M. Graham: Risk estimation systems in clinical use: SCORE, HeartScore, Framingham, PROCAM, ASSIGN and QRISK * 4: Anton F. H. Stalenhoef: Primary dyslipidaemias * 5: Rafael Carmena and José T Real: Secondary dyslipidemias * 6: Jonathan Morrell and Jacqueline Morrell: Diet and lifestyle * 7: D. John Betteridge: Pharmacological therapy: Statins * 8: D. John Betteridge: Pharmacological therapy: Non-Statin Drugs * 9: Anthony S. Wierzbicki: Combination therapy for the management of hyperlipidaemia * 10: D. John Betteridge: Recent lipid-lowering trials in perspective: Implications for therapy * 11: Manish Kalla and Julian Halcox: Vascular imaging * 12: John Reckless: Common problems in lipid management
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Shop der buecher.de GmbH & Co. KG Bürgermeister-Wegele-Str. 12, 86167 Augsburg Amtsgericht Augsburg HRA 13309
